![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » CELERA SELLS DRUG PROGRAM TO SCHERING AG
CELERA SELLS DRUG PROGRAM TO SCHERING AG
Celera Genomics has gotten out of the drug-development business. The Rockville-based biotechnology company said Wednesday it sold a small-molecule drug program for the treatment of autoimmune diseases to German pharmaceutical giant Schering AG.
Washington Business Journal
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct